SEC Form 4 · accession 0000899243-18-027471
BIODELIVERY SCIENCES INTERNATIONAL INC · BDSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott M. Plesha
Officer — See Remarks
Period of report
Oct 17, 2018
Accepted (ET)
Oct 25, 2018 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001103021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 17, 2018 | A | 18,750 | $0.00 | A | 212,338 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Oct 17, 2018 | A | 18,750 | D | — | Oct 17, 2018 | Common Stock | 18,750 | 0 | D |
Explanation of responses
- F1The shares of common stock were acquired by the Reporting Person as a result of the vesting of the performance-based Restricted Stock Units granted to the Reporting Person on September 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended, subject to certain performance measures.
Remarks
President and Chief Commercial Officer